31P NMR study of improvement in oxidative phosphorylation by vitamins K3 and C in a patient with a defect in electron transport at complex III in skeletal muscle.
about
Treatment for mitochondrial disordersTreatment for mitochondrial disordersVitamin C: update on physiology and pharmacologyTargeting the prodromal stage of Alzheimer's disease: bioenergetic and mitochondrial opportunitiesGlucose metabolism following human traumatic brain injury: methods of assessment and pathophysiological findings.Succinate supplementation improves metabolic performance of mixed glial cell cultures with mitochondrial dysfunction.Mitochondrial respiratory chain disorders and the liver.Focally perfused succinate potentiates brain metabolism in head injury patientsMitochondrial reactive oxygen species (ROS) and ROS-induced ROS release.Clinical mitochondrial genetics.Mitochondrial encephalomyopathy and complex III deficiency associated with a stop-codon mutation in the cytochrome b gene.Epidemiology and treatment of mitochondrial disorders.Mutations in mitochondrial DNA as a cause of exercise intolerance.Development of lipophilic cations as therapies for disorders due to mitochondrial dysfunction.Alzheimer's disease: role of aging in pathogenesis.Effects of thyroid hormones on skeletal muscle bioenergetics. In vivo phosphorus-31 magnetic resonance spectroscopy study of humans and rats.The development of mitochondrial medicine.Design and engineering of a man-made diffusive electron-transport proteinRole and treatment of mitochondrial DNA-related mitochondrial dysfunction in sporadic neurodegenerative diseases.A phase II clinical and pharmacokinetic study of Lonidamine in patients with advanced breast cancerNatural Product Screening Reveals Naphthoquinone Complex I Bypass Factors.Alzheimer's disease: A hypothesis on pathogenesis.Mitochondrial Respiratory Defect Causes Dysfunctional Lactate Turnover via AMP-activated Protein Kinase Activation in Human-induced Pluripotent Stem Cell-derived Hepatocytes.NMR spectroscopy for clinical medicine. Animal models and clinical examples.Phosphorus magnetic resonance spectroscopy studies of the role of mitochondria in the disease process.Diagnosis and treatment of mitochondrial myopathiesReview of clinical trials for mitochondrial disorders: 1997-2012.First principles design of a core bioenergetic transmembrane electron-transfer protein.Liver disease in mitochondrial disorders.New treatments for mitochondrial disease-no time to drop our standards.Multiple controls of oxidative metabolism in living tissues as studied by phosphorus magnetic resonance.Prenatal expression of a lethal genetic defect in carbohydrate metabolism in mice.Mitochondrial myopathies involving the respiratory chain: a biochemical analysis.Skeletal muscle phosphocreatine recovery in exercise-trained humans is dependent on O2 availability.Different characteristics between menadione and menadione sodium bisulfite as redox mediator in yeast cell suspension.Experimentally induced defects of mitochondrial metabolism in rat skeletal muscle. Biological effects of the NADH: coenzyme Q reductase inhibitor diphenyleneiodonium.[Myopathy due to succinate cytochrome C oxidoreductase deficiency: possible defect of complex II of the respiratory chain]Biochemical and genetic studies in a family with mitochondrial myopathy.An alternative, non-intrauterine hypothesis, based on maternal mitochondrial oocyte inheritance, to explain inconsistent findings of birth weight on (breast) cancer risk.Insight into age-related macular degeneration: new vision in sight.
P2860
Q24200432-C13AAF60-C9C9-4889-9B46-76073E2BC445Q24244543-700AAE19-813C-4445-9BEC-ED63BA13E851Q24654791-D14AC377-827F-4655-963C-23C5FCA3F867Q27338799-6F2E71B8-5BCE-4FFE-A847-B0F9E1DA4CFCQ30870829-9D82B3B4-6B79-4535-8207-85F15496AA18Q33682527-02295625-2CF8-468C-BAC3-0911B79C7E75Q33759088-C4F6483D-48CC-4A62-B94B-C3C067C6D522Q33828684-631133A0-B6C7-4D0C-A9E0-0B450EC2DD5AQ33913079-B8553993-B215-43E7-B07C-DCC85DA9F6B5Q33955376-8B908136-74FE-423A-89E0-12D8C5AE5268Q34144271-F6A05EF7-528D-47C7-A2F0-E0C265A3BB00Q34386766-6C2C2242-B40B-4A90-90BB-6D33DF40183CQ34420013-4BB4E3C4-CDDD-4B26-A4B2-30C12676659BQ34452604-49895362-475C-4346-A230-9568F4399D6CQ34614555-D121F8A9-11DA-4F8D-AB77-AF1191E0C2DFQ35589180-9AFF36FD-BD03-4AB8-8E05-E2240444C296Q35744478-971DA209-C103-474B-BC07-174FE26C612DQ35794045-9CEB331C-0F34-4E55-B337-E3D0E198E694Q35958359-1659D4AE-EA95-4891-973E-8AD8C15143C5Q35993793-ED111638-C2BF-4005-BD3C-951E4452CA16Q36131234-9E7604BB-9C66-4AA2-A02B-5DEF1AC2E5E6Q36271097-0AFF212A-5707-446E-9C90-7FD07E57BA98Q36444101-3CCCC41A-F919-4325-88BC-B4E1AED95A05Q36448278-46D4F3CA-8699-420B-9DDF-89A9FB009426Q36459111-54FE6492-7E8E-4483-9550-2E4F69EB885FQ36634939-DDB67CA7-4612-4743-A045-8D5BD17D0459Q36762846-AB992CBC-DA7D-44A4-B06B-7EF53F03ECAEQ36840077-E458DF36-DF08-49FF-87FA-19F6F4B36A9CQ36903648-C4CDE201-8AF8-4DD5-8FF6-7B12B5A3AD32Q37140299-237EDE45-0034-4C73-9833-15CE05D423AFQ37411297-F32885BB-33F7-4995-859C-99ED126DE3A4Q37683346-1764C287-B9AA-4B51-B4DB-300939CD67C9Q39509031-F235DCAA-8E40-463F-BF0D-C51D57BDB2C2Q41672278-F044029D-9EEA-4364-94A5-F655A9080EFDQ41683139-16720252-0AC1-4BB3-91A1-AC9295000185Q42005317-19A33211-8D1B-41B4-85A8-87C8B6645392Q42022538-1E05BC2C-A08F-42A4-98EB-2B80DCF41D0EQ42547278-20B35FFE-AE7C-4731-A7E7-E2DA9322EA77Q43220359-2152EDA9-8F18-4421-88FB-A5E9EDCEE0ECQ43586539-64CD2EA4-5053-4D83-B9D8-027A283F415A
P2860
31P NMR study of improvement in oxidative phosphorylation by vitamins K3 and C in a patient with a defect in electron transport at complex III in skeletal muscle.
description
1984 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1984 թվականի հունիսին հրատարակված գիտական հոդված
@hy
article publié dans les Procee ...... f the United States of America
@fr
artículu científicu espublizáu en 1984
@ast
im Juni 1984 veröffentlichter wissenschaftlicher Artikel
@de
scientific article (publication date: June 1984)
@en
wetenschappelijk artikel (gepubliceerd op 1984/06/01)
@nl
наукова стаття, опублікована в червні 1984
@uk
مقالة علمية (نشرت في يونيو 1984)
@ar
name
31P NMR study of improvement i ...... omplex III in skeletal muscle.
@ast
31P NMR study of improvement i ...... omplex III in skeletal muscle.
@en
type
label
31P NMR study of improvement i ...... omplex III in skeletal muscle.
@ast
31P NMR study of improvement i ...... omplex III in skeletal muscle.
@en
prefLabel
31P NMR study of improvement i ...... omplex III in skeletal muscle.
@ast
31P NMR study of improvement i ...... omplex III in skeletal muscle.
@en
P2093
P2860
P921
P3181
P356
P1476
31P NMR study of improvement i ...... complex III in skeletal muscle
@en
P2093
N. G. Kennaway
N. R. Buist
R. A. Capaldi
V. M. Darley-Usmar
W. J. Bank
P2860
P304
P3181
P356
10.1073/PNAS.81.11.3529
P407
P577
1984-06-01T00:00:00Z